Psoriatic arthritis (PsA) is a chronic inflammatory condition that affects approximately 112 per 100,000 adults worldwide. It ...
Although metabolic syndrome is associated with higher PsA disease activity, it is not associated with higher PsA-related ...
Patients with hidradenitis suppurativa are at increased risk of developing several common inflammatory arthropathies in the years following diagnosis.
Treatment with deucravacitinib in patients with active PsA showed higher response rates and improvement in quality of life ...
The arrival of biosimilars like Celltrion's STEQEYMA and Biocon's YESINTEK is shaking up the psoriatic arthritis market, challenging blockbuster biologics with cost-effective alternatives. As ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results